Replimune Group, Inc.

NasdaqGS:REPL Rapport sur les actions

Capitalisation boursière : US$1.0b

Replimune Group Gestion

Gestion contrôle des critères 2/4

Le PDG Replimune Group est Sush Patel, nommé en Apr2024, a un mandat de moins d'un an. détient directement 0.074% des actions de la société, d'une valeur de $ 751.70K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.2 ans et 6.4 ans.

Informations clés

Sush Patel

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur généralless than a year
Propriété du PDG0.07%
Durée moyenne d'occupation des postes de direction1.2yrs
Durée moyenne du mandat des membres du conseil d'administration6.4yrs

Mises à jour récentes de la gestion

Recent updates

Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Nov 23
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Replimune: Strong Data In A Highly Differentiated Space

Sep 03

Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?

Aug 16
Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?

Replimune: Continuing To Justify The Bear Thesis (For Now)

May 22

Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Feb 06
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer

Jan 23

Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)

Dec 25
Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)

Is Replimune Group (NASDAQ:REPL) A Risky Investment?

Jul 13
Is Replimune Group (NASDAQ:REPL) A Risky Investment?

Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?

Apr 05
Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?

A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Jan 06
A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Replimune secures $200M term loan

Oct 07

Replimune: Recent Developments Strengthen Bull Thesis

Aug 12

Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Aug 06
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?

Replimune Group GAAP EPS of -$0.78 misses by $0.15

Aug 04

Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate

Jun 24
Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate

We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate

Apr 04
We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate

Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth

Dec 16
Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth

Replimune: In The 'Buy Zone' Again

Oct 01

Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Sep 02
Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)

Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business

May 24
Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business

Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic

Apr 30

We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow

Feb 08
We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow

Replimune Group EPS misses by $0.03

Feb 04

Dosing underway in Replimune's early-stage cancer study with gene therapy

Jan 05

Analyse de la rémunération des PDG

Comment la rémunération de Sush Patel a-t-elle évolué par rapport aux bénéfices de Replimune Group?
DateRémunération totaleSalaireBénéfices de l'entreprise
Sep 30 2024n/an/a

-US$213m

Jun 30 2024n/an/a

-US$220m

Mar 31 2024n/an/a

-US$216m

Dec 31 2023n/an/a

-US$210m

Sep 30 2023n/an/a

-US$199m

Jun 30 2023n/an/a

-US$182m

Mar 31 2023US$3mUS$447k

-US$174m

Dec 31 2022n/an/a

-US$157m

Sep 30 2022n/an/a

-US$147m

Jun 30 2022n/an/a

-US$133m

Mar 31 2022US$7mUS$394k

-US$118m

Rémunération vs marché: Données insuffisantes pour établir si la rémunération totale de Sush est raisonnable par rapport à des entreprises de taille similaire sur le marché US.

Rémunération et revenus: La rémunération de Sush a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Sush Patel (53 yo)

less than a year

Titularisation

US$2,595,003

Compensation

Dr. Sushil Patel, also known as Sush,Ph D, is CEO & Director of Replimune Group, Inc. from April 1, 2024. Dr. Patel served as the Chief Commercial Officer at Replimune Group, Inc. since May 3, 2021 and ser...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Philip Astley-Sparke
Executive Chairman9.8yrsUS$6.02m1.86%
$ 19.0m
Emily Hill
Chief Financial Officer1.2yrsUS$3.61m0.017%
$ 177.5k
Konstantinos Xynos
Chief Medical Officer1.9yrsUS$2.45m0.017%
$ 169.4k
Sushil Patel
CEO & Directorless than a yearUS$2.60m0.074%
$ 751.7k
Robert Coffin
Founderno dataUS$5.72m2.57%
$ 26.2m
Andrew Schwendenman
Chief Accounting Officer & Treasurer1.5yrspas de données0.010%
$ 104.8k
Christopher Sarchi
Chief Commercial Officer1.9yrspas de données0.017%
$ 177.7k
Paul Bullock
Chief Manufacturing Officer & Framingham Site Headless than a yearpas de donnéespas de données

1.2yrs

Durée moyenne de l'emploi

53yo

Âge moyen

Gestion expérimentée: L'équipe de direction de REPL n'est pas considérée comme expérimentée (ancienneté moyenne 1.2 ans), ce qui suggère une nouvelle équipe.


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Philip Astley-Sparke
Executive Chairman9.8yrsUS$6.02m1.86%
$ 19.0m
Sushil Patel
CEO & Directorless than a yearUS$2.60m0.074%
$ 751.7k
Robert Coffin
Founder9.8yrsUS$5.72m2.57%
$ 26.2m
Joseph Slattery
Independent Director7.1yrsUS$362.60k0.0097%
$ 99.5k
Hyam Levitsky
Independent Non-Executive Director6.5yrsUS$355.10k0%
$ 0
Paolo Pucci
Independent Director4.6yrsUS$360.10k0%
$ 0
Madhavan Balachandran
Directorless than a yearpas de donnéespas de données
Kapil Dhingra
Independent Director7.3yrsUS$357.60k0%
$ 0
Christy Oliger
Independent Director2.9yrsUS$352.60k0%
$ 0
Dieter Weinand
Lead Independent Director6.4yrsUS$516.81k0%
$ 0
Veleka Peeples-Dyer
Independent Director1.4yrsUS$667.97k0%
$ 0

6.4yrs

Durée moyenne de l'emploi

59yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de REPL sont considérés comme expérimentés (ancienneté moyenne 6.4 ans).